IncFact
Company Profiles: Revenue, Growth, Competition

VBI VACCINES Revenue, Growth & Competitor Profile

DBA PAULSON CAPITAL CORP
DBA PAULSON CAPITAL (DELAWARE) CORP.
DBA VBI Vaccines Inc/BC
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing

Company Profile & Annual Report for VBI Vaccines

Access the complete profile.

VBI Vaccines Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes32541
5417 Scientific Research & Development Services
Address222 Third Street
Cambridge, MA 02142

www.vbivaccines.com


VBI Vaccines's annual revenues are $1-$10 million (see exact revenue data) and has 1-10 employees. It is classified as operating in the Medicinal & Botanical Manufacturing industry.


VBI Vaccines's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

VBI Vaccines is a publicly traded company on NCM using the ticker symbol VBIV. Detailed information on company financials and operating reports can be found here: NCM: VBIV



VBI Vaccines Annual Revenue and Growth Rate

VBI Vaccines Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: VBI Vaccines's revenues are gauged from an analysis of company filings.



Investor Activity

VBI Vaccines has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
June 22, 2020 3 17%$5 MM
Complete list of funding rounds and total amounts in the Company Report




Recession Risk

Determine whether VBI Vaccines grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof VBI Vaccines is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Medicinal & Botanical Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of VBI Vaccines's Largest Competitors

A competitive analysis shows these companies are in the same general field as VBI Vaccines, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
PANACEA BIOMATXResearch Triangle Park, NC100 
TMUNITY THERAPEUTICSPhiladelphia, PA56 




Nearby Competitors

These companies are similar in business line and location to VBI Vaccines. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
BIOGENCambridge, MA100 
SAREPTA THERAPEUTICSCambridge, MA2 
ABCAMCambridge, MA2 
BRAINTREE LABORATORIESBraintree, MA1 
FOGHORN THERAPEUTICSCambridge, MA1 
RUBIUS THERAPEUTICSCambridge, MA1 




Future Competition: VBI Vaccines's Fastest Growing Competitors

These companies are in the same general field as VBI Vaccines and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
VBI Vaccines Competitors